NEW YORK – Schrödinger, a privately held company working on new drug discovery through advanced molecular simulations, has closed an $85 million financing to support continued growth and innovation of its computational platform and expansion of its drug discovery pipeline. The Bill and Melinda Gates Foundation Trust and WuXi AppTec’s Corporate Venture Fund co-led the […]
